A Special Report on Gene Therapy

Front Cover
John Wiley & Sons, Apr 14, 2000 - Business & Economics - 291 pages
0 Reviews
This special report on Gene Therapy Companies by K.K. Jain provides an up-to-date overview of the gene therapy industry. It contains a wealth of very practical information on 105 companies. For each company, information is available on the people to contact, their contact details, a corporate history, the company's technologies and products, financial data, patents held, products in clinical trials, collaborations with other companies and selected publications from the company's scientists. Almost 200 companies were initially considered for inclusion but just over 100 companies were finally selected as they fulfilled the necessary criteria to be classified as a 'Gene Therapy Company,', defined broadly to include cell therapy companies. Not all of the companies devote their activity exclusively to gene therapy but they have sufficient relevance to be included. As part of this project, new companies were discovered that have not been reported in other publications or on the internet. Dr. Jain has spared no effort to ensure that the information is up-to-date and accurate at the time of publishing. In most instances, the information was reviewed by the companies to correct any outdated information or to add any complementary or recent information. In addition to the detailed descriptions of each company, the data is also presented in summary tabular form so that at a glance the reader can identify collaborations within the gene therapy industry, or determine which companies are pursuing strategies involving viral, non-viral or other approaches to gene therapy, and which diseases are being targetted. Given that much of the gene therapy research and development is currently being carried out within the industrial sector, it is important for scientists, managers and investors to have the relevant information at their fingertips. This special report provides that information in one accurate, easy to consult and up-to-date source.
 

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

introduction
3
Basics of genetherapy
6
Different strategies for genetherapy
7
Classification of genetherapy companies
10
Profiles of genetherapy companies
15
Aastrom Biosciences
17
Aldevron
21
Alexion
23
Genzyme General
133
Genzyme Molecular Oncology
137
Geron
141
Hepavec
143
Hoffman La Roche
145
Human GenOme Sciences
147
immuneResponse
151
ImmunoDesigned Molecules
153

Alphaax
25
ALZA
29
AmCell
31
AMRAD
33
ApoptoGen
35
Ariad
37
Athersys
41
Avigen
43
Bavarian Nordic
47
BioRad
49
BioBeliance
51
BiosenseWebster
53
BioStratum
55
Bovector
57
Boehringer Ingelheim
59
Boston Scientific Corporation
61
BTG International
63
Calydon
65
Cantab
67
Cell Genesys
69
Celltech Chiroscience
73
Chiron
77
Chromos
79
Clontech
81
Cobra
83
Collateral
85
Copernicus
87
Cowance
89
Cytoherapeutics
91
Danbiocyst
93
Dendreon
95
DeveloGen
99
DNAVEC
101
Endovasc
103
Eurogene
105
GOT
107
Contents Genelabs
109
Gene Therapy Systems
111
GeneticTherapy
113
Genetix
115
Genetronics
117
Genopoietic
121
Genovo
123
GenStar
125
Genteric
127
Genvec
129
NEX
157
introgen
161
introGene
163
invivoGen
167
Kimeragen
171
Lifelechnologies
175
LXRBiotechnology
177
Medeva
179
MediCiene
181
Merck
183
Modex
185
Molecular Medicine
187
MOLMED
189
NatureTechnology
191
Neurotech
193
NeuroVir
195
Nexel
197
Novartis
201
NSGene
203
Oxford Biomedica
209
Phogen
213
Powderlect
215
Prolifix
217
Qiagen
219
Quadrant
221
Quantum
223
RHeoGene
227
Ribozyme Pharmaceuticals
229
RPR Gencell
231
ScheringPloughCanji
235
Selective Genetics
237
Signal
241
Stem Cell Sciences
243
StressGen
245
SyStemix
249
Targeted Genetics
251
Theratechnologies
255
Therion
257
Titan
259
Tosk
261
Transkaryotic
267
Varian
275
Vion
283
Weighted scale for evaluating genetherapy technologies
291
Copyright

Common terms and phrases

Bibliographic information